Joincare Pharmaceutical Group Industry Co., Ltd. (600380) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Joincare Pharmaceutical Group Industry Co., Ltd.

Why is Joincare Pharmaceutical Group Industry Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 3.51% and Operating profit at 4.46% over the last 5 years

Flat results in Sep 25

ROCE(HY) Lowest at 9.31%
NET SALES(Q) Lowest at CNY 3,579.48 MM
OPERATING PROFIT(Q) Lowest at CNY 678.44 MM

With ROE of 20.84%, it has a attractive valuation with a 1.53 Price to Book Value

Over the past year, while the stock has generated a return of -2.29%, its profits have risen by 4.3% ; the PEG ratio of the company is 1.7
At the current price, the company has a high dividend yield of 1.7

Below par performance in long term as well as near term

Along with generating -2.29% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Joincare Pharmaceutical Group Industry Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Joincare Pharmaceutical Group Industry Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Joincare Pharmaceutical Group Industry Co., Ltd.

-6.0%

-0.40

25.52%

China Shanghai Composite

15.17%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.51%

EBIT Growth (5y)

4.46%

EBIT to Interest (avg)

30.27

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.57

Sales to Capital Employed (avg)

0.76

Tax Ratio

17.19%

Dividend Payout Ratio

26.61%

Pledged Shares

Institutional Holding

ROCE (avg)

58.67%

ROE (avg)

22.08%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.53

EV to EBIT

4.18

EV to EBITDA

3.23

EV to Capital Employed

2.63

EV to Sales

0.83

PEG Ratio

1.70

Dividend Yield

1.71%

ROCE (Latest)

62.86%

ROE (Latest)

20.84%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -6.79% (YoY

CASH AND EQV(HY)

Highest at CNY 31,767.78 MM

DEBT-EQUITY RATIO (HY)

Lowest at -62.58 %

DEBTORS TURNOVER RATIO(HY)

Highest at 3.38 times

-5What is not working for the Company

ROCE(HY)

Lowest at 9.31%

NET SALES(Q)

Lowest at CNY 3,579.48 MM

OPERATING PROFIT(Q)

Lowest at CNY 678.44 MM

PRE-TAX PROFIT(Q)

Lowest at CNY 750.07 MM

Here's what is working for Joincare Pharmaceutical Group Industry Co., Ltd.

Cash and Eqv

Highest at CNY 31,767.78 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio

Lowest at -62.58 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio

Highest at 3.38 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -6.79% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Joincare Pharmaceutical Group Industry Co., Ltd.

Net Sales

Lowest at CNY 3,579.48 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 678.44 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Pre-Tax Profit

Lowest at CNY 750.07 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)